{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:45:42Z","timestamp":1785775542330,"version":"3.56.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jctube.2026.100633","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:06:31Z","timestamp":1784045191000},"page":"100633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tuberculin responsiveness as a surrogate prognostic marker in hospitalized HIV-infected patients with tuberculosis in a resource-limited setting"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2484-8123","authenticated-orcid":false,"given":"Murali K.","family":"Yanamadala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jctube.2026.100633_bb0005","series-title":"Global Tuberculosis Report 2024","author":"World Health Organization","year":"2024"},{"issue":"9","key":"10.1016\/j.jctube.2026.100633_bb0010","first-page":"839","article-title":"Risk of development of tuberculosis in HIV-infected patients","volume":"4","author":"Swaminathan","year":"2000","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.jctube.2026.100633_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1164\/ajrccm.151.1.7812542","article-title":"Accelerated course of human immunodeficiency virus infection after tuberculosis","volume":"151","author":"Whalen","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"9267","key":"10.1016\/j.jctube.2026.100633_bb0020","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(00)04639-0","article-title":"Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1","volume":"357","author":"Harries","year":"2001","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jctube.2026.100633_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-119-3-199308010-00002","article-title":"Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons","volume":"119","author":"Markowitz","year":"1993","journal-title":"Ann Intern Med"},{"issue":"4 Pt 2","key":"10.1016\/j.jctube.2026.100633_bb0030","first-page":"S221","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.jctube.2026.100633_bb0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.1992.03480030047035","article-title":"Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users","volume":"267","author":"Graham","year":"1992","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jctube.2026.100633_bb0040","first-page":"191","article-title":"Tuberculin testing: method and interpretation","volume":"1","author":"Nayfield","year":"1997","journal-title":"Lippincotts Prim Care Pract"},{"key":"10.1016\/j.jctube.2026.100633_bb0045","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry","volume":"854","author":"World Health Organization","year":"1995","journal-title":"Report of a WHO expert committee WHO Tech Rep Ser"},{"issue":"3","key":"10.1016\/j.jctube.2026.100633_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0035-9203(02)90103-3","article-title":"Moderate to severe malnutrition in patients with tuberculosis is a risk factor for early death","volume":"96","author":"Zachariah","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"14","key":"10.1016\/j.jctube.2026.100633_bb0055","first-page":"1869","article-title":"Tuberculin skin testing in patients with HIV-associated tuberculosis: a prospective cohort study in Tanzania","volume":"20","author":"Cobelens","year":"2006","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.jctube.2026.100633_bb0060","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jama.1992.03490040080029","article-title":"High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy","volume":"268","author":"Selwyn","year":"1992","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jctube.2026.100633_bb0065","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-119-3-199308010-00003","article-title":"Risk for developing tuberculosis among anergic patients infected with HIV","volume":"119","author":"Moreno","year":"1993","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.jctube.2026.100633_bb0070","first-page":"1260","article-title":"Tuberculosis and \u201clate presenters\u201d in the era of antiretroviral therapy in India","volume":"63","author":"Gupte","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jctube.2026.100633_bb0075","article-title":"Incidence rate of mortality and its predictors among tuberculosis and human immunodeficiency virus coinfected patients on antiretroviral therapy in Ethiopia: systematic review and meta-analysis","volume":"11","author":"Alemu","year":"2024","journal-title":"Front Med (Lausanne)"}],"container-title":["Journal of Clinical Tuberculosis and Other Mycobacterial Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579426000550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405579426000550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:56:30Z","timestamp":1785772590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405579426000550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":15,"alternative-id":["S2405579426000550"],"URL":"https:\/\/doi.org\/10.1016\/j.jctube.2026.100633","relation":{},"ISSN":["2405-5794"],"issn-type":[{"value":"2405-5794","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuberculin responsiveness as a surrogate prognostic marker in hospitalized HIV-infected patients with tuberculosis in a resource-limited setting","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Tuberculosis and Other Mycobacterial Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jctube.2026.100633","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100633"}}